MyFinsight
Home
About
Contact
Download
Download image
Net loss
-$163,141K
(23.66%↑ Y/Y)
Interest income
$9,363K
(-46.58%↓ Y/Y)
Change in fair value of
equity investments
$1,335K
(18.14%↑ Y/Y)
(provision for) benefit
from income taxes
$168K
(-5.08%↓ Y/Y)
Loss before
(provision for) benefit...
-$162,973K
(23.68%↑ Y/Y)
Total other income
$10,470K
(-41.06%↓ Y/Y)
Grant
$305K
Other expense, net
-$228K
(74.47%↑ Y/Y)
Loss from operations
-$173,443K
(25.02%↑ Y/Y)
Total revenues
$240K
(-89.92%↓ Y/Y)
Collaboration Revenue
-$65K
Total operating
expenses
$173,683K
(-25.68%↓ Y/Y)
Cost of revenue
-$11K
(-122.00%↓ Y/Y)
Selling, general and
administrative
$22,231K
(-13.65%↓ Y/Y)
Research and development
$151,463K
(-22.40%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
vir: the income statement
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)